20 verified results
1g
Tirzepatide API | 1g
Produced in China | COA | GMP certified $ 406
2g
Tirzepatide API | 2g
Produced in China | COA | GMP certified $ 812
5g
Tirzepatide API | 5g
Produced in China | COA | GMP certified $ 2,030
Custom
Tirzepatide API | Custom
Produced in China | COA | GMP certified On Request
Producer CDMO Produced in Asia | Employees: 25+ | Audit Report: Certifications: CoA All certificates MSDS BSE/TSE ISO9001 CoA
Producer CDMO Produced in Asia | Employees: 10+ | Audit Report: Certifications: CoA All certificates MSDS BSE/TSE CoA
Take control of your API sourcing Submit a Special Inquiry and have Pharmaoffer activate verified suppliers.
Producer CDMO Produced in Asia | Audit Report: Certifications: CoA All certificates MSDS ISO9001 CoA
Producer Produced in Asia | Employees: 200 | Audit Report: Certifications: CoA All certificates MSDS BSE/TSE ISO9001 CoA
Producer CDMO Produced in Asia | Employees: 50+ | Audit Report: Certifications: CoA | GMP See all 6 certificates All certificates GMP FDA USDMF ISO9001 CoA WC
Producer Produced in Asia | Employees: 1500+ | Audit Report: Certifications: CoA | GMP All certificates GMP USDMF MSDS BSE/TSE CoA
Get full market intelligence report €399,- All Tirzepatide data. Full access. Full negotiation power
Producer Produced in Asia | Employees: 373 | Audit Report: Certifications: CoA | GMP All certificates GMP USDMF MSDS BSE/TSE CoA
Producer CDMO Produced in Asia | Employees: 200 | Audit Report: Certifications: CoA All certificates MSDS BSE/TSE CoA
Get full market intelligence report
Distributor Produced in Europe | Employees: 50 | Audit Report: Certifications: CoA | GMP See all 6 certificates All certificates GMP USDMF MSDS ISO9001 KDMF CoA
Distributor Produced in Asia | Employees: 25 | Audit Report: Certifications: CoA | GMP See all 6 certificates All certificates GMP FDA MSDS BSE/TSE ISO9001 CoA
Producer Produced in Asia | Employees: 400+ | Audit Report: Certifications: CoA All certificates MSDS BSE/TSE CoA
Producer Produced in Asia | Audit Report: Certifications: CoA | GMP All certificates GMP MSDS BSE/TSE ISO9001 CoA
Producer Produced in Asia | Audit Report: Certifications: CoA All certificates CoA
Distributor Produced in North America | Employees: 50+ | Audit Report: Certifications: CoA | GMP All certificates GMP MSDS BSE/TSE ISO9001 CoA
Producer Produced in Asia | Employees: 250+ | Audit Report: Certifications: CoA All certificates USDMF MSDS CoA
Producer Produced in Asia | Employees: 250+ | Audit Report: Certifications: CoA | GMP All certificates GMP USDMF MSDS BSE/TSE CoA
Take control of your API sourcing
Producer Produced in Asia | Employees: 1000+ | Audit Report: Certifications: CoA All certificates FDA USDMF MSDS BSE/TSE CoA
Producer Produced in North America | Audit Report: Certifications: CoA | GMP All certificates GMP MSDS CoA
Producer Produced in Asia | Employees: 60 | Audit Report: Certifications: CoA | CEP All certificates GMP CEP CoA
Trusted by 30,000+ registered pharma professionals: Reach multinationals, SMEs, compounding pharmacies & more!
Procaps Pfizer Reckitt Sanofi Blau Abbvie
A medication that supports glycemic control in adults with type 2 diabetes and assists chronic weight management in obese or overweight patients with related comorbid conditions.
Alimentary Tract and Metabolism Amino Acids, Peptides, and Proteins Blood Glucose Lowering Agents Drugs Used in Diabetes Gastrointestinal Hormones GLP-1 Agonists
Generic name Tirzepatide
Molecule type biotech
CAS number 2023788-19-2
DrugBank ID DB15171
Approval status Approved drug, Investigational drug
ATC code A10BX16
Tirzepatide (CAS 2023788-19-2) is a 39‑amino‑acid synthetic peptide conjugated to a C20 fatty diacid designed to act as a dual agonist at the glucose‑dependent insulinotropic polypeptide and glucagon‑like peptide‑1 receptors. It is indicated as an adjunct to diet and physical activity for glycemic control in adults with type 2 diabetes and for chronic weight management in adults with obesity or overweight with at least one weight‑associated comorbidity. It has not been studied in patients with a history of pancreatitis and is not indicated for type 1 diabetes. In Europe, it may be used as monotherapy or in combination with other antidiabetic therapies. Approved products include Mounjaro for type 2 diabetes and Zepbound for weight management.
Tirzepatide lowers glucose by stimulating first‑ and second‑phase insulin secretion and suppressing glucagon release in a glucose‑dependent manner. It delays gastric emptying, decreases fasting and postprandial glucose, reduces food intake, and can improve insulin sensitivity. High albumin binding due to the fatty‑diacid conjugate contributes to a prolonged half‑life that supports once‑weekly administration.
The mechanism of action involves dual receptor agonism. GLP‑1 receptor activation enhances glucose‑stimulated insulin secretion, slows gastric transit, and reduces glucagon levels while influencing central p
